Global Choroidal Neovascularization Drug Market Research Report 2018

  • May 2018
  • By QY Research
  • 113 pages
  • Report Id: 170613

Global Choroidal Neovascularization Drug Market Research Report 2018

  • May 2018
  • By QY Research
  • 113 pages
  • Report Id: 170613
This report studies the global Choroidal Neovascularization Drug market status and forecast, categorizes the global Choroidal Neovascularization Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

In 2017, the global Choroidal Neovascularization Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report
Cellphire, Inc.
Chrysalis BioTherapeutics, Inc.
Cleveland BioLabs, Inc.
Cumberland Pharmaceuticals, Inc.
Diffusion Pharmaceuticals Inc.
Eli Lilly and Company
GNI Group Ltd.
Humanetics Corporation
INSYS Therapeutics, Inc.
Meabco A/S
Neumedicines Inc.
Onconova Therapeutics, Inc.
PharmaIN Corporation
Pluristem Therapeutics Inc.
ProCertus BioPharm Inc.
RDD Pharma Ltd.
RedHill Biopharma Ltd.
RxBio, Inc.
Soligenix, Inc.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
Asia-Pacific
South America
Middle East & Africa

The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
AVMOC-001
BB-3
BBT-007
DG-3
Entolimod
EWA-001
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Clinic
Hospital
Others

The study objectives of this report are:
To analyze and study the global Choroidal Neovascularization Drug sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Choroidal Neovascularization Drug manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Choroidal Neovascularization Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Choroidal Neovascularization Drug Manufacturers
Choroidal Neovascularization Drug Distributors/Traders/Wholesalers
Choroidal Neovascularization Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, offers customizations according to the companys specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Choroidal Neovascularization Drug market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Choroidal Neovascularization Drug Market Research Report 2018
1 Choroidal Neovascularization Drug Market Overview
1.1 Product Overview and Scope of Choroidal Neovascularization Drug
1.2 Choroidal Neovascularization Drug Segment by Type (Product Category)
1.2.1 Global Choroidal Neovascularization Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Choroidal Neovascularization Drug Production Market Share by Type (Product Category) in 2017
1.2.3 AVMOC-001
1.2.4 BB-3
1.2.5 BBT-007
1.2.6 DG-3
1.2.7 Entolimod
1.2.8 EWA-001
1.2.9 Others
1.3 Global Choroidal Neovascularization Drug Segment by Application
1.3.1 Choroidal Neovascularization Drug Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Choroidal Neovascularization Drug Market by Region (2013-2025)
1.4.1 Global Choroidal Neovascularization Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 Asia-Pacific Status and Prospect (2013-2025)
1.4.5 South America Status and Prospect (2013-2025)
1.4.6 Middle East & Africa Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Choroidal Neovascularization Drug (2013-2025)
1.5.1 Global Choroidal Neovascularization Drug Revenue Status and Outlook (2013-2025)
1.5.2 Global Choroidal Neovascularization Drug Capacity, Production Status and Outlook (2013-2025)

2 Global Choroidal Neovascularization Drug Market Competition by Manufacturers
2.1 Global Choroidal Neovascularization Drug Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Choroidal Neovascularization Drug Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Choroidal Neovascularization Drug Production and Share by Manufacturers (2013-2018)
2.2 Global Choroidal Neovascularization Drug Revenue and Share by Manufacturers (2013-2018)
2.3 Global Choroidal Neovascularization Drug Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Choroidal Neovascularization Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Choroidal Neovascularization Drug Market Competitive Situation and Trends
2.5.1 Choroidal Neovascularization Drug Market Concentration Rate
2.5.2 Choroidal Neovascularization Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Choroidal Neovascularization Drug Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Choroidal Neovascularization Drug Capacity and Market Share by Region (2013-2018)
3.2 Global Choroidal Neovascularization Drug Production and Market Share by Region (2013-2018)
3.3 Global Choroidal Neovascularization Drug Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 Asia-Pacific Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 South America Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Middle East & Africa Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Choroidal Neovascularization Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Choroidal Neovascularization Drug Consumption by Region (2013-2018)
4.2 North America Choroidal Neovascularization Drug Production, Consumption, Export, Import (2013-2018)
4.3 Europe Choroidal Neovascularization Drug Production, Consumption, Export, Import (2013-2018)
4.4 Asia-Pacific Choroidal Neovascularization Drug Production, Consumption, Export, Import (2013-2018)
4.5 South America Choroidal Neovascularization Drug Production, Consumption, Export, Import (2013-2018)
4.6 Middle East & Africa Choroidal Neovascularization Drug Production, Consumption, Export, Import (2013-2018)

5 Global Choroidal Neovascularization Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Choroidal Neovascularization Drug Production and Market Share by Type (2013-2018)
5.2 Global Choroidal Neovascularization Drug Revenue and Market Share by Type (2013-2018)
5.3 Global Choroidal Neovascularization Drug Price by Type (2013-2018)
5.4 Global Choroidal Neovascularization Drug Production Growth by Type (2013-2018)

6 Global Choroidal Neovascularization Drug Market Analysis by Application
6.1 Global Choroidal Neovascularization Drug Consumption and Market Share by Application (2013-2018)
6.2 Global Choroidal Neovascularization Drug Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Choroidal Neovascularization Drug Manufacturers Profiles/Analysis
7.1 Cellphire, Inc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Choroidal Neovascularization Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Cellphire, Inc. Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Chrysalis BioTherapeutics, Inc.
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Choroidal Neovascularization Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Cleveland BioLabs, Inc.
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Choroidal Neovascularization Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Cumberland Pharmaceuticals, Inc.
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Choroidal Neovascularization Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Diffusion Pharmaceuticals Inc.
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Choroidal Neovascularization Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Eli Lilly and Company
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Choroidal Neovascularization Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Eli Lilly and Company Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 GNI Group Ltd.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Choroidal Neovascularization Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 GNI Group Ltd. Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Humanetics Corporation
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Choroidal Neovascularization Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Humanetics Corporation Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 INSYS Therapeutics, Inc.
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Choroidal Neovascularization Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Meabco A/S
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Choroidal Neovascularization Drug Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Meabco A/S Choroidal Neovascularization Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Neumedicines Inc.
7.12 Onconova Therapeutics, Inc.
7.13 PharmaIN Corporation
7.14 Pluristem Therapeutics Inc.
7.15 ProCertus BioPharm Inc.
7.16 RDD Pharma Ltd.
7.17 RedHill Biopharma Ltd.
7.18 RxBio, Inc.
7.19 Soligenix, Inc.

8 Choroidal Neovascularization Drug Manufacturing Cost Analysis
8.1 Choroidal Neovascularization Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Choroidal Neovascularization Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Choroidal Neovascularization Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Choroidal Neovascularization Drug Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Choroidal Neovascularization Drug Market Forecast (2018-2025)
12.1 Global Choroidal Neovascularization Drug Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Choroidal Neovascularization Drug Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Choroidal Neovascularization Drug Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Choroidal Neovascularization Drug Price and Trend Forecast (2018-2025)
12.2 Global Choroidal Neovascularization Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Choroidal Neovascularization Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Choroidal Neovascularization Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 Asia-Pacific Choroidal Neovascularization Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 South America Choroidal Neovascularization Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Middle East & Africa Choroidal Neovascularization Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Choroidal Neovascularization Drug Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Choroidal Neovascularization Drug Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures

Figure Picture of Choroidal Neovascularization Drug
Figure Global Choroidal Neovascularization Drug Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Choroidal Neovascularization Drug Production Market Share by Types (Product Category) in 2017
Figure Product Picture of AVMOC-001
Table Major Manufacturers of AVMOC-001
Figure Product Picture of BB-3
Table Major Manufacturers of BB-3
Figure Product Picture of BBT-007
Table Major Manufacturers of BBT-007
Figure Product Picture of DG-3
Table Major Manufacturers of DG-3
Figure Product Picture of Entolimod
Table Major Manufacturers of Entolimod
Figure Product Picture of EWA-001
Table Major Manufacturers of EWA-001
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Choroidal Neovascularization Drug Consumption (K Pcs) by Applications (2013-2025)
Figure Global Choroidal Neovascularization Drug Consumption Market Share by Applications in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Choroidal Neovascularization Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025)
Figure North America Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure South America Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East & Africa Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Choroidal Neovascularization Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Choroidal Neovascularization Drug Capacity, Production (K Pcs) Status and Outlook (2013-2025)
Figure Global Choroidal Neovascularization Drug Major Players Product Capacity (K Pcs) (2013-2018)
Table Global Choroidal Neovascularization Drug Capacity (K Pcs) of Key Manufacturers (2013-2018)
Table Global Choroidal Neovascularization Drug Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Choroidal Neovascularization Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Choroidal Neovascularization Drug Capacity (K Pcs) of Key Manufacturers in 2018
Figure Global Choroidal Neovascularization Drug Major Players Product Production (K Pcs) (2013-2018)
Table Global Choroidal Neovascularization Drug Production (K Pcs) of Key Manufacturers (2013-2018)
Table Global Choroidal Neovascularization Drug Production Share by Manufacturers (2013-2018)
Figure 2017 Choroidal Neovascularization Drug Production Share by Manufacturers
Figure 2017 Choroidal Neovascularization Drug Production Share by Manufacturers
Figure Global Choroidal Neovascularization Drug Major Players Product Revenue (Million USD) (2013-2018)
Table Global Choroidal Neovascularization Drug Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Choroidal Neovascularization Drug Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Choroidal Neovascularization Drug Revenue Share by Manufacturers
Table 2018 Global Choroidal Neovascularization Drug Revenue Share by Manufacturers
Table Global Market Choroidal Neovascularization Drug Average Price (USD/Pcs) of Key Manufacturers (2013-2018)
Figure Global Market Choroidal Neovascularization Drug Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Choroidal Neovascularization Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Choroidal Neovascularization Drug Product Category
Figure Choroidal Neovascularization Drug Market Share of Top 3 Manufacturers
Figure Choroidal Neovascularization Drug Market Share of Top 5 Manufacturers
Table Global Choroidal Neovascularization Drug Capacity (K Pcs) by Region (2013-2018)
Figure Global Choroidal Neovascularization Drug Capacity Market Share by Region (2013-2018)
Figure Global Choroidal Neovascularization Drug Capacity Market Share by Region (2013-2018)
Figure 2017 Global Choroidal Neovascularization Drug Capacity Market Share by Region
Table Global Choroidal Neovascularization Drug Production by Region (2013-2018)
Figure Global Choroidal Neovascularization Drug Production (K Pcs) by Region (2013-2018)
Figure Global Choroidal Neovascularization Drug Production Market Share by Region (2013-2018)
Figure 2017 Global Choroidal Neovascularization Drug Production Market Share by Region
Table Global Choroidal Neovascularization Drug Revenue (Million USD) by Region (2013-2018)
Table Global Choroidal Neovascularization Drug Revenue Market Share by Region (2013-2018)
Figure Global Choroidal Neovascularization Drug Revenue Market Share by Region (2013-2018)
Table 2017 Global Choroidal Neovascularization Drug Revenue Market Share by Region
Figure Global Choroidal Neovascularization Drug Capacity, Production (K Pcs) and Growth Rate (2013-2018)
Table Global Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table North America Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Europe Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Asia-Pacific Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table South America Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Middle East & Africa Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Global Choroidal Neovascularization Drug Consumption (K Pcs) Market by Region (2013-2018)
Table Global Choroidal Neovascularization Drug Consumption Market Share by Region (2013-2018)
Figure Global Choroidal Neovascularization Drug Consumption Market Share by Region (2013-2018)
Figure 2017 Global Choroidal Neovascularization Drug Consumption (K Pcs) Market Share by Region
Table North America Choroidal Neovascularization Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Europe Choroidal Neovascularization Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Asia-Pacific Choroidal Neovascularization Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table South America Choroidal Neovascularization Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Middle East & Africa Choroidal Neovascularization Drug Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Global Choroidal Neovascularization Drug Production (K Pcs) by Type (2013-2018)
Table Global Choroidal Neovascularization Drug Production Share by Type (2013-2018)
Figure Production Market Share of Choroidal Neovascularization Drug by Type (2013-2018)
Figure 2017 Production Market Share of Choroidal Neovascularization Drug by Type
Table Global Choroidal Neovascularization Drug Revenue (Million USD) by Type (2013-2018)
Table Global Choroidal Neovascularization Drug Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Choroidal Neovascularization Drug by Type (2013-2018)
Figure 2017 Revenue Market Share of Choroidal Neovascularization Drug by Type
Table Global Choroidal Neovascularization Drug Price (USD/Pcs) by Type (2013-2018)
Figure Global Choroidal Neovascularization Drug Production Growth by Type (2013-2018)
Table Global Choroidal Neovascularization Drug Consumption (K Pcs) by Application (2013-2018)
Table Global Choroidal Neovascularization Drug Consumption Market Share by Application (2013-2018)
Figure Global Choroidal Neovascularization Drug Consumption Market Share by Applications (2013-2018)
Figure Global Choroidal Neovascularization Drug Consumption Market Share by Application in 2017
Table Global Choroidal Neovascularization Drug Consumption Growth Rate by Application (2013-2018)
Figure Global Choroidal Neovascularization Drug Consumption Growth Rate by Application (2013-2018)
Table Cellphire, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cellphire, Inc. Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cellphire, Inc. Choroidal Neovascularization Drug Production Growth Rate (2013-2018)
Figure Cellphire, Inc. Choroidal Neovascularization Drug Production Market Share (2013-2018)
Figure Cellphire, Inc. Choroidal Neovascularization Drug Revenue Market Share (2013-2018)
Table Chrysalis BioTherapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Production Growth Rate (2013-2018)
Figure Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Production Market Share (2013-2018)
Figure Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Revenue Market Share (2013-2018)
Table Cleveland BioLabs, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Production Growth Rate (2013-2018)
Figure Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Production Market Share (2013-2018)
Figure Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Revenue Market Share (2013-2018)
Table Cumberland Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Production Growth Rate (2013-2018)
Figure Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Production Market Share (2013-2018)
Figure Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Revenue Market Share (2013-2018)
Table Diffusion Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Production Growth Rate (2013-2018)
Figure Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Production Market Share (2013-2018)
Figure Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Revenue Market Share (2013-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Choroidal Neovascularization Drug Production Growth Rate (2013-2018)
Figure Eli Lilly and Company Choroidal Neovascularization Drug Production Market Share (2013-2018)
Figure Eli Lilly and Company Choroidal Neovascularization Drug Revenue Market Share (2013-2018)
Table GNI Group Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GNI Group Ltd. Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GNI Group Ltd. Choroidal Neovascularization Drug Production Growth Rate (2013-2018)
Figure GNI Group Ltd. Choroidal Neovascularization Drug Production Market Share (2013-2018)
Figure GNI Group Ltd. Choroidal Neovascularization Drug Revenue Market Share (2013-2018)
Table Humanetics Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Humanetics Corporation Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Humanetics Corporation Choroidal Neovascularization Drug Production Growth Rate (2013-2018)
Figure Humanetics Corporation Choroidal Neovascularization Drug Production Market Share (2013-2018)
Figure Humanetics Corporation Choroidal Neovascularization Drug Revenue Market Share (2013-2018)
Table INSYS Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Production Growth Rate (2013-2018)
Figure INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Production Market Share (2013-2018)
Figure INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Revenue Market Share (2013-2018)
Table Meabco A/S Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Meabco A/S Choroidal Neovascularization Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Meabco A/S Choroidal Neovascularization Drug Production Growth Rate (2013-2018)
Figure Meabco A/S Choroidal Neovascularization Drug Production Market Share (2013-2018)
Figure Meabco A/S Choroidal Neovascularization Drug Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Choroidal Neovascularization Drug
Figure Manufacturing Process Analysis of Choroidal Neovascularization Drug
Figure Choroidal Neovascularization Drug Industrial Chain Analysis
Table Raw Materials Sources of Choroidal Neovascularization Drug Major Manufacturers in 2017
Table Major Buyers of Choroidal Neovascularization Drug
Table Distributors/Traders List
Figure Global Choroidal Neovascularization Drug Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Choroidal Neovascularization Drug Price (Million USD) and Trend Forecast (2018-2025)
Table Global Choroidal Neovascularization Drug Production (K Pcs) Forecast by Region (2018-2025)
Figure Global Choroidal Neovascularization Drug Production Market Share Forecast by Region (2018-2025)
Table Global Choroidal Neovascularization Drug Consumption (K Pcs) Forecast by Region (2018-2025)
Figure Global Choroidal Neovascularization Drug Consumption Market Share Forecast by Region (2018-2025)
Figure North America Choroidal Neovascularization Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure North America Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Choroidal Neovascularization Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Europe Choroidal Neovascularization Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Choroidal Neovascularization Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Asia-Pacific Choroidal Neovascularization Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Choroidal Neovascularization Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure South America Choroidal Neovascularization Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure South America Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table South America Choroidal Neovascularization Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Middle East & Africa Choroidal Neovascularization Drug Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Middle East & Africa Choroidal Neovascularization Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Middle East & Africa Choroidal Neovascularization Drug Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Table Global Choroidal Neovascularization Drug Production (K Pcs) Forecast by Type (2018-2025)
Figure Global Choroidal Neovascularization Drug Production (K Pcs) Forecast by Type (2018-2025)
Table Global Choroidal Neovascularization Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Choroidal Neovascularization Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Choroidal Neovascularization Drug Price Forecast by Type (2018-2025)
Table Global Choroidal Neovascularization Drug Consumption (K Pcs) Forecast by Application (2018-2025)
Figure Global Choroidal Neovascularization Drug Consumption (K Pcs) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source